ask="1.1100"
ask_size="14000"
average_daily_volume="858755"
bid="0.7600"
bid_size="1000"
book_value="0.6060"
change="+0.0173"
change_from_200_day_moving_average="-1.0068"
change_from_50_day_moving_average="-0.0574"
change_from_52_week_high="-3.9926"
change_From_52_week_low="0.4373"
change_in_percent="+1.8804%"
close="0.9373"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.2370"
ebitda="-8.78M"
eps_estimate_current_year="-1.1200"
eps_estimate_next_quarter="-0.2500"
eps_estimate_next_year="-0.3200"
ex_dividend_date="N/A"
float_shares="7029000"
high="0.9401"
high_52_weeks="4.9299"
last_trade_date="3/6/2017"
last_trade_price="0.9373"
last_trade_size="100"
last_trade_time="3:59pm"
low="0.9000"
low_52_weeks="0.5000"
market_capitalization="6.69M"
moving_average_200_day="1.9441"
moving_average_50_day="0.9947"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.3300"
open="0.9200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-51.7880%"
percent_change_from_50_day_moving_average="-5.7711%"
percent_change_from_52_week_high="-80.9874%"
percent_change_from_52_week_low="+87.4600%"
previous_close="0.9200"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.5182"
price_per_sales="2.5700"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="1.0600"
stock_exchange="NCM"
symbol="OPXA"
volume="61442"
weeks_range_52="0.5000 - 4.9299"
